Literature DB >> 21422663

The T wave inversion score is useful for evaluating the time-course of acute pulmonary embolism.

Tomoyuki Kunishima1, Yoshihiro J Akashi, Fumihiko Miyake, Naoyoshi Aoyama, Hideyasu Kohshoh, Hideaki Yoshino, Kenji Seki, Kazuo Matsumoto, Taiji Furukawa, Koichiro Yoshioka, Hirohisa Amano, Isao Taguchi, Hiroyuki Sugimura, Yuji Murakawa.   

Abstract

BACKGROUND: The 12-lead electrocardiogram (ECG) has relatively poor specificity for identifying acute pulmonary embolism (APE). The aim of this study was to investigate ECG abnormalities according to 2 different criteria and their usefulness for assessing changes in APE. METHODS AND
RESULTS: Fifty-two APE patients underwent ECG examinations in the acute and chronic phases. ECG abnormalities were assessed according to Stein's criteria (QRS complex abnormalities and T wave inversion in any lead except aV(L), III, aV(R), or V₁) and Kosuge's criteria (T wave inversion in any lead except aV(R) or aV(L)). Many patients had electrocardiographic abnormalities in the acute phase, but no specific abnormalities were found. According to Kosuge's criteria, the frequency of T wave inversion was higher than that of abnormal QRS complexes and T wave inversion according to Stein's criteria (P < 0.01). In 20 cases with preclinical ECG records, the time-course of changes in the T wave inversion score (total numbers of T wave inversions per patient) was examined. The peak T wave inversion score was noted at 3 days after onset (P < 0.01).
CONCLUSIONS: These results suggest that the T wave inversion score, calculated according to Kosuge's criteria, is useful for predicting the time-course of APE.

Entities:  

Mesh:

Year:  2011        PMID: 21422663     DOI: 10.1253/circj.cj-10-0121

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  1 in total

1.  Prognostic value of Tpeak-Tend interval in patients with acute pulmonary embolism.

Authors:  Abdullah Icli; Mehmet Kayrak; Hakan Akilli; Alpay Aribas; Mukremin Coskun; Sumeyye Fatma Ozer; Kurtulus Ozdemir
Journal:  BMC Cardiovasc Disord       Date:  2015-09-03       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.